Focke Ziemssen1, Georg Spital2. Show Affiliations » 1. Center for Ophthalmology, Eberhard-Karl University Tuebingen, Tuebingen, Germany. Electronic address: focke.ziemssen@med.uni-tuebingen.de. 2. Institute of Ophthalmology, St Franziskus Hospital, Muenster, Germany.
Abstract
Entities: Disease
Mesh： See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useBevacizumabBlood Glucose/metabolismDiabetic Retinopathy/drug therapyDiabetic Retinopathy/metabolismFemaleHumansMacular Edema/drug therapyMaleVascular Endothelial Growth Factor A/antagonists & inhibitors
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBlood GlucoseVascular Endothelial Growth Factor ABevacizumab
Year: 2013 PMID： 24360342 DOI： 10.1016/j.jdiacomp.2013.11.001
Source DB: PubMed Journal: J Diabetes Complications ISSN： 1056-8727 Impact factor: 2.852